C57BL/6N-Adipor2tm1b(EUCOMM)Hmgu/H
| Status | Only small colony available |
| EMMA ID | EM:16357 |
| Citation information | RRID:IMSR_EM:16357 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
| International strain name | C57BL/6N-Adipor2tm1b(EUCOMM)Hmgu/H |
| Alternative name | HEPD0751_3_F06 |
| Strain type | Targeted Mutant Strains |
| Allele/Transgene symbol | Adipor2tm1b(EUCOMM)Hmgu |
| Gene/Transgene symbol | Adipor2 |
| Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
| Provider | Mary Lyon Centre at MRC Harwell |
| Provider affiliation | Mary Lyon Centre at MRC Harwell |
| Genetic information | This mouse line originates from EUCOMM ES clone HEPD0751_3_F06. For further details on the construction of this clone see the page at the IMPC portal. The critical exon(s) were flanked by loxP sites, and subsequent cre expression excised this critical sequence resulting in a knockout reporter allele. Click here for more information on EUCOMM final vectors. |
| Phenotypic information | Potential phenotyping data in the IMPC portal |
| References | None available |
Information from EMMA
| Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
IMPC phenotypes (allele matching)
MGI phenotypes (gene matching)
- abnormal abdominal fat pad morphology / MGI
- decreased circulating LDL cholesterol level / MGI
- decreased circulating HDL cholesterol level / MGI
- seminiferous tubule degeneration / MGI
- abnormal spermatogenesis / MGI
- hyperactivity / MGI
- hyperglycemia / MGI
- abnormal glucose homeostasis / MGI
- increased circulating insulin level / MGI
- abnormal lipid homeostasis / MGI
- increased brain weight / MGI
- decreased circulating triglyceride level / MGI
- oligozoospermia / MGI
- decreased circulating insulin level / MGI
- decreased pancreatic beta cell number / MGI
- abnormal hormone level / MGI
- decreased lean body mass / MGI
- decreased testis weight / MGI
- increased energy expenditure / MGI
- increased adiponectin level / MGI
- decreased epididymis weight / MGI
- decreased circulating VLDL cholesterol level / MGI
- decreased circulating cholesterol level / MGI
- improved glucose tolerance / MGI
- impaired glucose tolerance / MGI
- insulin resistance / MGI
- homeostasis/metabolism phenotype / MGI
- decreased percent body fat/body weight / MGI
- increased circulating glucose level / MGI
- decreased susceptibility to diet-induced obesity / MGI
- abnormal brown fat cell morphology / MGI
- decreased fat cell size / MGI
- decreased gonadal fat pad weight / MGI
- decreased renal fat pad weight / MGI
- decreased liver triglyceride level / MGI
- abnormal adaptive thermogenesis / MGI
- impaired adaptive thermogenesis / MGI
- increased food intake / MGI
- decreased brown adipose tissue mass / MGI
- multinucleated giant male germ cells / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).
